PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Kynam Capital Management, LP's Holding History (CIK: 0001907884)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 390,792 Value ($000) $15,085 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 456,369 Value ($000) $20,537 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 800,000 Value ($000) $27,720 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 1,144,242 Value ($000) $33,103 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 2,004,875 Value ($000) $45,972 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 1,818,657 Value ($000) $30,335 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 975,298 Value ($000) $26,938 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 1,375,000 Value ($000) $31,625 Avg Close $16.79 Range $10.62 - $25.69
Q4 2022
Shares 520,922 Value ($000) $5,683 Avg Close $8.44 Range $7.24 - $11.46
Q3 2022
Shares 519,212 Value ($000) $4,377 Avg Close $9.46 Range $7.68 - $11.97